blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2771087

EP2771087 - A METHOD FOR EXTRACORPOREAL ELIMINATION OF ONE OR MORE COMPONENTS FROM BLOOD [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.07.2022
Database last updated on 14.09.2024
FormerExamination is in progress
Status updated on  14.09.2018
Most recent event   Tooltip29.07.2022Application deemed to be withdrawnpublished on 31.08.2022  [2022/35]
Applicant(s)For all designated states
Glycorex Transplantation AB
Sölvegatan 41
223 70 Lund / SE
[2014/36]
Inventor(s)01 / NILSSON, Kurt
Andjaktsvägen 6
S-226 53 Lund / SE
 [2014/36]
Representative(s)AWA Sweden AB
Box 5117
200 71 Malmö / SE
[N/P]
Former [2014/36]Henriksson, Dan Ragnar Mikael
Awapatent AB
P.O. Box 5117
200 71 Malmö / SE
Application number, filing date12843200.229.10.2012
WO2012SE51173
Priority number, dateSE2011000080328.10.2011         Original published format: SE 1100803
[2014/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013062479
Date:02.05.2013
Language:EN
[2013/18]
Type: A1 Application with search report 
No.:EP2771087
Date:03.09.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 02.05.2013 takes the place of the publication of the European patent application.
[2014/36]
Search report(s)International search report - published on:SE02.05.2013
(Supplementary) European search report - dispatched on:EP13.05.2015
ClassificationIPC:B01D15/08, G01N33/80, A61M1/30, B01J20/32, B01D15/38
[2015/24]
CPC:
B01D15/3804 (EP,US); B01D15/3809 (EP,US); B01D15/3828 (EP,US);
B01J20/3255 (EP,US); B01J20/3274 (EP,US); A61M1/3679 (EP,US)
Former IPC [2014/36]B01D15/08, G01N33/80, A61M1/30
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/36]
TitleGerman:VERFAHREN ZUR EXTRAKORPORALEN AUSSCHEIDUNG VON EINEM ODER MEHREREN BESTANDTEILEN AUS BLUT[2014/36]
English:A METHOD FOR EXTRACORPOREAL ELIMINATION OF ONE OR MORE COMPONENTS FROM BLOOD[2014/36]
French:PROCÉDÉ POUR L'ÉLIMINATION EXTRACORPORELLE D'UN OU DE PLUSIEURS CONSTITUANTS À PARTIR DU SANG[2014/36]
Entry into regional phase28.05.2014National basic fee paid 
28.05.2014Search fee paid 
28.05.2014Designation fee(s) paid 
28.05.2014Examination fee paid 
Examination procedure28.05.2014Examination requested  [2014/36]
11.12.2015Amendment by applicant (claims and/or description)
12.09.2018Despatch of a communication from the examining division (Time limit: M06)
22.03.2019Reply to a communication from the examining division
11.05.2020Despatch of a communication from the examining division (Time limit: M06)
11.11.2020Reply to a communication from the examining division
22.09.2021Despatch of a communication from the examining division (Time limit: M06)
05.04.2022Application deemed to be withdrawn, date of legal effect  [2022/35]
28.04.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/35]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.09.2018
Request for further processing for:The application is deemed to be withdrawn due to failure to file a copy of earlier search results or a statement of non-availability
21.06.2016Request for further processing filed
21.06.2016Full payment received (date of receipt of payment)
Request granted
29.06.2016Decision despatched
Fees paidRenewal fee
02.10.2014Renewal fee patent year 03
27.04.2016Renewal fee patent year 04
31.10.2016Renewal fee patent year 05
17.04.2018Renewal fee patent year 06
05.03.2019Renewal fee patent year 07
16.09.2019Renewal fee patent year 08
22.09.2020Renewal fee patent year 09
14.09.2021Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.10.201504   M06   Fee paid on   27.04.2016
31.10.201706   M06   Fee paid on   17.04.2018
31.10.201807   M06   Fee paid on   05.03.2019
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0158510  (GLYCOREX TRANSPLANTATION AB [SE], et al) [X] 1-20 * the whole document *;
 [X]US6686457  (NILSSON KURT [SE]) [X] 1-20* the whole document *;
 [X]WO2011046504  (GLYCOREX AB [SE], et al) [X] 1-20 * page 5, line 1 - page 6, line 8 * * page 8, line 1 - page 9, line 11 * * figure 1 *
International search[X]WO0001730  (A & SCIENCE INVEST AB [SE], et al);
 [X]US6444655  (NILSSON KURT [SE]);
 [X]US2002146814  (NILSSON KURT G I [SE]);
 [A]US2007224652  (HOLGERSSON JAN [SE], et al);
 [X]WO2010037785  (UNIV GENT [BE], et al);
 [X]  - RYDBERG L. ET AL., "In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose", TRANSPL INT, (2005), vol. 17, pages 666 - 672, XP019323995

DOI:   http://dx.doi.org/10.1007/s00147-004-0775-7
 [A]  - GENBERG H. ET AL., "The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation", NEPHROLOGY DIALYSIS TRANSPLANTATION, (2011), vol. 26, pages 2394 - 2400, XP055066349

DOI:   http://dx.doi.org/10.1093/ndt/gfr237
 [A]  - CODDENS A. ET AL., "Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Eschrichia coli", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2009), vol. 284, no. 15, pages 9713 - 9726, XP008119049

DOI:   http://dx.doi.org/10.1074/jbc.M807866200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.